Skip to main content

Table 4 The demographic, pathologic and clinical details of the MSA patients

From: Analysis of COQ2gene in multiple system atrophy

 

Mayo clinic MSA series

 

Pathologically-confirmed MSA

Clinically- diagnosed MSA

Total

Total number

97

58

155

Male/Female

59/38

34/24

93/62

Positive family history of MSA

0

2

2

Positive family history of PD

1

10

11

Mean age at onset, SD

59.1 ± 8.7 (39–78)

64.7 ± 8.8 (48–83)

61.6 ± 9.1 (39–83)

Mean age at death, SD

67.5, 8.5 (47–86)

NA

NA

MSA-P/MSA-C/MSA-PC/Unclassified*

36/13/47/1

49/9/0/0

85/22/47/1

Ethnicity (Race), %

   

White (Caucasian)

93

47

140

African-American

1

4

5

Asian

2

0

2

Hispanic

1

0

1

More than One Race/NA

0

7

7

  1. Abbreviation: MSA-P parkinsonian variant of multiple system atrophy, MSA-C cerebellar variant of multiple system atrophy, MSA-PC mixed type of multiple system atrophy with parkinsonism and cerebellar ataxia, NA not available, PD Parkinson’s disease, SD standard deviation. *One MSA patient was unclassified.